The alternatives
Vaylen scores 88/100 (grade B+, ranked #10) on The Verdict Score. Here are the top-rated GLP-1 providers we'd weigh against it — same six-factor rubric, and no score is adjusted for payment.
The most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.
CoreAge Rx scores 94/100 to Vaylen's 88, and our Vaylen vs CoreAge Rx ruling sets the two out factor by factor.
A physician-founded telehealth that carries a genuinely broad menu — compounded, advertised brand-name and oral GLP-1 plus longevity lines — ships to all 50 states, and posts transparent all-inclusive pricing that starts around $194/mo on an annual compounded semaglutide plan.
RxSpan MD scores 86/100 to Vaylen's 88; our full write-up on RxSpan MD has the pricing conditions and the caveats in detail.
An established telehealth pharmacy with a broad metabolic and hormone catalog.
Invigor Medical matches Vaylen at 88/100; the full Invigor Medical review has the pricing conditions and the caveats in detail.
A rare oral GLP tablet alongside both injectables, with the full plan table published on-site — though the headline $99 and $179 rates are 12-month prepay floors, not what a month-to-month patient pays.
HealthRX scores 86/100 to Vaylen's 88; the full HealthRX review has the pricing conditions and the caveats in detail.
Earns its keep on pricing transparency — every tier is published, dose-flat and includes combo and microdose options — but the verdict holds it back for a compounded-only formulary and a state map it won't show.
Enhance MD scores 85/100 to Vaylen's 88; our full write-up on Enhance MD has the pricing conditions and the caveats in detail.
A cheap compounded entry with a real brand-Ozempic path and nationwide coverage — but the $179 is a yearly-subscription rate, and Gala publishes no month-to-month price at all, which is what the verdict now docks it hardest for.
Gala Health scores 86/100 to Vaylen's 88; our Gala Health ruling in full has the pricing conditions and the caveats in detail.
Carries one of the deepest published catalogs in the ranking — compounded semaglutide and tirzepatide plus needle-free oral and microdosed routes, PT-141, intranasal NAD+ and a wall of recovery peptides — and backs it with a checkable LegitScript certification and HIPAA compliance, but the verdict docks it hard because every line is compounded, not FDA-approved, and the pricing turns opaque the moment you look past the headline GLP-1 tiers.
Telos Rx scores 85/100 to Vaylen's 88; our Telos Rx ruling in full has the pricing conditions and the caveats in detail.
See the complete rankings or head to the comparison hub.
Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Not medical advice; see our disclosure.